+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID05379595

Study of Amivantamab Alone and With Standard Chemotherapy in Advanced or Metastatic Colorectal Cancer

Led by Janssen Research & Development, LLC · Updated on 2026-11-03

225

Participants Needed

53

Research Sites

210 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the anti-tumor activity and safety of amivantamab, alone and combined with standard chemotherapy, in participants with advanced or metastatic colorectal cancer. This study focuses on different groups based on prior treatments and tumor characteristics, aiming to find effective dosing for amivantamab combined with standard chemotherapy. The study includes participants with specific genetic tumor profiles and performance status, assessing treatment effects in various cohorts. Participants receive intravenous infusions of amivantamab alone or with chemotherapy regimens such as mFOLFOX6 or FOLFIRI, depending on their cohort and prior treatment history. The treatment cycles last 28 days and continue until the end of treatment visit, which occurs up to 30 days after discontinuation. Dose levels and schedules vary by cohort, with some receiving monotherapy and others combination therapies at doses determined in earlier phases. Throughout the study, participants undergo physical exams, performance status assessments, laboratory tests, vital sign monitoring, and adverse event tracking. Tumor response and disease control are measured using standard criteria over up to four years and three months. Biopsies are required for certain cohorts to assess tumor characteristics. Safety and treatment effects are closely monitored during and after treatment to evaluate amivantamabs impact.

CONDITIONS

Brief Title

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

Research Team

S

Study Contact

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here